Investment
Features
FeesSafety
Academy
More
Pluang+

VK2735 shows 22% weight loss at week 33 with flexible dosing and good tolerability in obesity study

Company Fundamentals
22 Sep 2026
PRNewsWire
View Source
Bullish
VK2735 shows 22% weight loss at week 33 with flexible dosing and good tolerability in obesity study

Viking Therapeutics reported that VK2735, a dual GLP-1/GIP receptor agonist, achieved up to 22% placebo-adjusted weight loss by week 33 in a study with no weight loss plateau observed. The drug maintained up to 97% of weight loss with every-other-week dosing and up to 90% with monthly dosing, offering flexible maintenance options. VK2735 was well tolerated with gastrointestinal side effects similar to placebo. The company plans to explore oral dosing and continue Phase 3 trials, aiming to provide new long-term obesity treatment options.

Viking Therapeutics' VK2735 study results provide context for readers interested in health sector developments. For readers following health stocks, here is Pluang's market snapshot as of Sep 22, 2026 18:11 WIB: Among 95 priced US health-sector stocks, 50 rose and 38 fell today. Alcon AG (ALC) gained 1.16% to USD 65.62 with a typical hold time of 68 days and 89% sell order activity, contrasting with GSK plc (GSK) which dropped 1.14% to USD 50.50 and saw 100% sell orders over a 91-day hold. BioNano Genomics Inc (BNGO) rose 1.09% to USD 1.85 with 90% sell orders and a shorter hold time of 49 days.

More News

01 Quantum to showcase quantum-secure AI encryption at GCXpo 2026 in Canada

01 Quantum to showcase quantum-secure AI encryption at GCXpo 2026 in Canada

01 Quantum Inc. has been selected by Invest Ottawa to exhibit at GCXpo 2026, where it will demonstrate its quantum-secure Fully Homomorphic Encryption (FHE) AI model. This technology enables encrypted AI processing for sensitive data like autonomous ...

Market News
Bullish
4 hours ago
UnitedHealth Group posts strong Q2 with margin recovery and growth outlook through 2028

UnitedHealth Group posts strong Q2 with margin recovery and growth outlook through 2028

UnitedHealth Group reported robust Q2 results with $112 billion in revenue and adjusted EPS of $6.38, showing significant margin improvements in both UnitedHealthcare and Optum Health segments. The company’s operational turnaround is driven by cost c...

Company Fundamentals
Bullish
4 hours ago
Betterware rated 'Buy' with 37% upside on insider buying and Latin America growth plans

Betterware rated 'Buy' with 37% upside on insider buying and Latin America growth plans

Betterware is rated a 'Buy' with a price target in the mid-$20s over two years, driven by insider purchases and expansion in Latin America. The Campos family, including the CEO and Chairman, recently bought over $2 million in shares around $16–$17, s...

Analyst Insights
Bullish
4 hours ago
AI investment may falter, boosting Bitcoin and gold as governments print money to cover losses.

AI investment may falter, boosting Bitcoin and gold as governments print money to cover losses.

Arthur Hayes argues that from 2022 to mid-2026, AI investment absorbed most global credit, limiting Bitcoin's gains. Now, doubts about AI profitability and accounting issues suggest the AI rally could be ending. Hayes predicts governments will respon...

Market News
Neutral
4 hours ago
$51M worth of Bitcoin dormant for 14 years moves amid recent price surge

$51M worth of Bitcoin dormant for 14 years moves amid recent price surge

Over $51 million worth of Bitcoin, untouched for 14.2 years, has recently moved following a significant price breakout in the crypto market. This Bitcoin, known as Satoshi-era Bitcoin, belongs to early holders who acquired it when prices were very lo...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App